• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体与病毒发病机制。

Complement and viral pathogenesis.

机构信息

Department of Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.

出版信息

Virology. 2011 Mar 15;411(2):362-73. doi: 10.1016/j.virol.2010.12.045. Epub 2011 Feb 2.

DOI:10.1016/j.virol.2010.12.045
PMID:21292294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3073741/
Abstract

The complement system functions as an immune surveillance system that rapidly responds to infection. Activation of the complement system by specific recognition pathways triggers a protease cascade, generating cleavage products that function to eliminate pathogens, regulate inflammatory responses, and shape adaptive immune responses. However, when dysregulated, these powerful functions can become destructive and the complement system has been implicated as a pathogenic effector in numerous diseases, including infectious diseases. This review highlights recent discoveries that have identified critical roles for the complement system in the pathogenesis of viral infection.

摘要

补体系统作为一种免疫监视系统,可快速应对感染。特定识别途径激活补体系统会触发蛋白酶级联反应,生成具有消除病原体、调节炎症反应和塑造适应性免疫反应功能的裂解产物。然而,当失调时,这些强大的功能可能会具有破坏性,补体系统已被认为是许多疾病(包括传染病)发病机制中的致病效应因子。本综述强调了最近的发现,这些发现确定了补体系统在病毒感染发病机制中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffc5/7111897/27f0ef8d68c9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffc5/7111897/165b7467ac63/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffc5/7111897/696644ac2fed/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffc5/7111897/27f0ef8d68c9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffc5/7111897/165b7467ac63/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffc5/7111897/696644ac2fed/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffc5/7111897/27f0ef8d68c9/gr3_lrg.jpg

相似文献

1
Complement and viral pathogenesis.补体与病毒发病机制。
Virology. 2011 Mar 15;411(2):362-73. doi: 10.1016/j.virol.2010.12.045. Epub 2011 Feb 2.
2
Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.补体蛋白作为可溶性模式识别受体对致病病毒的作用。
Viruses. 2021 May 2;13(5):824. doi: 10.3390/v13050824.
3
The imitation game: a viral strategy to subvert the complement system.模仿游戏:一种颠覆补体系统的病毒策略。
FEBS Lett. 2020 Aug;594(16):2518-2542. doi: 10.1002/1873-3468.13856. Epub 2020 Jun 23.
4
'Complementing' viral infection: mechanisms for evading innate immunity.“辅助性”病毒感染:逃避天然免疫的机制
Trends Microbiol. 2003 Oct;11(10):449-52. doi: 10.1016/j.tim.2003.08.004.
5
Virus complement evasion strategies.病毒补体逃避策略。
J Gen Virol. 2003 Jan;84(Pt 1):1-15. doi: 10.1099/vir.0.18709-0.
6
Complement and immunity to viruses.补体与病毒免疫
Immunol Rev. 1997 Oct;159:69-77. doi: 10.1111/j.1600-065x.1997.tb01007.x.
7
Virus-Encoded Complement Regulators: Current Status.病毒编码的补体调节剂:现状。
Viruses. 2021 Jan 29;13(2):208. doi: 10.3390/v13020208.
8
The role of antibody and complement in the control of viral infections.抗体和补体在控制病毒感染中的作用。
J Invest Dermatol. 1984 Jul;83(1 Suppl):121s-127s. doi: 10.1111/1523-1747.ep12281847.
9
Role of complement in immune regulation and its exploitation by virus.补体在免疫调节中的作用及其被病毒利用的情况。
Viral Immunol. 2007 Dec;20(4):505-24. doi: 10.1089/vim.2007.0061.
10
Complement evasion by human pathogens.人类病原体的补体逃避
Nat Rev Microbiol. 2008 Feb;6(2):132-42. doi: 10.1038/nrmicro1824.

引用本文的文献

1
Oncolytic Herpes Simplex Virus Therapy: Latest Advances, Core Challenges, and Future Outlook.溶瘤单纯疱疹病毒疗法:最新进展、核心挑战与未来展望。
Vaccines (Basel). 2025 Aug 20;13(8):880. doi: 10.3390/vaccines13080880.
2
Viral infections and related fatal adverse events associated with complement inhibitors for PNH: a real-world pharmacovigilance analysis in FAERS.阵发性睡眠性血红蛋白尿症补体抑制剂相关的病毒感染及相关致命不良事件:基于FAERS的真实世界药物警戒分析
Front Pharmacol. 2025 Aug 11;16:1639685. doi: 10.3389/fphar.2025.1639685. eCollection 2025.
3
Infection Characteristics, Transcriptomics, and Metabolomics of African Swine Fever Virus SY-1 Strain in Orally Infected Weaned Landrace Piglets.

本文引用的文献

1
The importance of natural IgM: scavenger, protector and regulator.天然 IgM 的重要性:清道夫、保护者和调节剂。
Nat Rev Immunol. 2010 Nov;10(11):778-86. doi: 10.1038/nri2849. Epub 2010 Oct 15.
2
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma.补体介导的 IL-17A 轴调节是实验性变应性哮喘严重程度的主要遗传决定因素。
Nat Immunol. 2010 Oct;11(10):928-35. doi: 10.1038/ni.1926. Epub 2010 Aug 29.
3
Complement-dependent transport of antigen into B cell follicles.
非洲猪瘟病毒SY-1株经口感染断奶长白仔猪后的感染特征、转录组学及代谢组学
Transbound Emerg Dis. 2025 Jul 14;2025:2453420. doi: 10.1155/tbed/2453420. eCollection 2025.
4
Clinical Value of Complement C3a, C5a, and sC5b-9 in Evaluating the Severity of Patients with Severe Fever with Thrombocytopenia Syndrome.补体C3a、C5a和sC5b-9在评估严重发热伴血小板减少综合征患者病情严重程度中的临床价值
J Inflamm Res. 2025 Jul 10;18:9001-9014. doi: 10.2147/JIR.S520425. eCollection 2025.
5
The hidden impact of producer cells on virion composition and infectivity.生产者细胞对病毒粒子组成和感染性的潜在影响。
Future Virol. 2025;20(3-4):113-123. doi: 10.1080/17460794.2025.2475669. Epub 2025 Mar 12.
6
Complement activity and autophagy are dysregulated in the lungs of patients with nonresolvable COVID-19 requiring lung transplantation.在需要肺移植的无法治愈的新冠肺炎患者的肺部,补体活性和自噬功能失调。
Respir Res. 2025 Feb 27;26(1):68. doi: 10.1186/s12931-025-03152-6.
7
Blood DNA virome associates with autoimmune diseases and COVID-19.血液DNA病毒组与自身免疫性疾病和COVID-19相关。
Nat Genet. 2025 Jan;57(1):65-79. doi: 10.1038/s41588-024-02022-z. Epub 2025 Jan 3.
8
A comparative analysis of Marburg virus-infected bat and human models from public high-throughput sequencing data.基于公开高通量测序数据的马尔堡病毒感染蝙蝠和人类模型的比较分析。
Int J Med Sci. 2025 Jan 1;22(1):1-16. doi: 10.7150/ijms.100696. eCollection 2025.
9
Immunity and Coagulation in COVID-19.新型冠状病毒肺炎中的免疫与凝血。
Int J Mol Sci. 2024 Oct 19;25(20):11267. doi: 10.3390/ijms252011267.
10
Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis.免疫球蛋白 G 和补体在多发性硬化症的神经退行性变中的主要作用。
Biomolecules. 2024 Sep 26;14(10):1210. doi: 10.3390/biom14101210.
补体依赖性抗原转运至 B 细胞滤泡。
J Immunol. 2010 Sep 1;185(5):2659-64. doi: 10.4049/jimmunol.1000522.
4
Complement: a key system for immune surveillance and homeostasis.补体:免疫监视和稳态的关键系统。
Nat Immunol. 2010 Sep;11(9):785-97. doi: 10.1038/ni.1923. Epub 2010 Aug 19.
5
Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin.直接补体限制黄病毒感染需要甘露糖结合凝集素识别聚糖。
Cell Host Microbe. 2010 Aug 19;8(2):186-95. doi: 10.1016/j.chom.2010.07.007.
6
Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.细小病毒科病毒补体酶抑制剂保护细胞内成熟病毒和感染细胞免受小鼠补体的影响。
J Virol. 2010 Sep;84(18):9128-39. doi: 10.1128/JVI.02677-09. Epub 2010 Jul 7.
7
Role and mechanism of action of complement in regulating T cell immunity.补体在调节 T 细胞免疫中的作用和机制。
Mol Immunol. 2010 Aug;47(13):2176-86. doi: 10.1016/j.molimm.2010.05.008. Epub 2010 Jun 18.
8
A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.严重急性呼吸综合征冠状病毒刺突糖蛋白上的一个单一的天冬酰胺连接的糖基化位点通过多种机制促进甘露糖结合凝集素的抑制作用。
J Virol. 2010 Sep;84(17):8753-64. doi: 10.1128/JVI.00554-10. Epub 2010 Jun 23.
9
Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile.微囊藻素,一种从铜绿微囊藻中分离得到的新型α(1,2)-甘露糖特异性凝集素,具有与环孢菌素 N 相当的抗 HIV-1 活性,但安全性更高。
J Biol Chem. 2010 Aug 6;285(32):24845-54. doi: 10.1074/jbc.M110.128546. Epub 2010 May 27.
10
Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.肌动蛋白结合素,一种广泛中和的原核凝集素,通过特异性靶向 gp120 包膜上的高甘露糖型聚糖来抑制 HIV-1 感染。
Antimicrob Agents Chemother. 2010 Aug;54(8):3287-301. doi: 10.1128/AAC.00254-10. Epub 2010 May 24.